Code
|
8205E
|
MA number
|
EU/1/24/1871/002
|
Product Form:
|
plu inu 5x5 µg + 5x0,5 ml susp. (liek.inj.skl. + striek.inj.napl.skl + 5xadaptér + 5xihla)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Pfizer Europe MA EEIG, Belgium
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
ATC:
|
J |
ANTIINFECTIVES FOR SYSTEMIC USE |
J07 |
VACCINES |
J07A |
BACTERIAL VACCINES |
J07AH |
Meningococcal vaccines |
J07AH11 |
Meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein |
|
Shelf life:
|
24 |
Container:
|
glass vial
|
Route of admin.:
|
Intramuscular use
|